共 126 条
[31]
Zhu O., Wang S., Huang X., Zhao C., Wang Y., Li X., Jia D., Ma C., Understanding the pathogenesis of coronary slow flow: Recent advances, Trends Cardiovasc. Med, 34, pp. 137-144, (2024)
[32]
Olson M.B., Kelsey S.F., Matthews K., Shaw L.J., Sharaf B.L., Pohost G.M., Cornell C.E., McGorray S.P., Vido D., Bairey Merz C.N., Symptoms, myocardial ischaemia and quality of life in women, Eur. Heart J, 24, pp. 1506-1514, (2003)
[33]
Reynolds H.R., Picard M.H., Spertus J.A., Peteiro J., Sendon J.L.L., Senior R., El-Hajjar M.C., Celutkiene J., Shapiro M.D., Pellikka P.A., Et al., Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study, Circulation, 144, pp. 1008-1023, (2021)
[34]
Mancini G.B.J., Hartigan P.M., Shaw L.J., Berman D.S., Hayes S.W., Bates E.R., Maron D.J., Teo K., Sedlis S.P., Chaitman B.R., Et al., Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): Coronary anatomy versus ischemia, JACC Cardiovasc. Interv, 7, pp. 195-201, (2014)
[35]
Rajendran P., Rengarajan T., Thangavel J., Nishigaki Y., Sakthisekaran D., Sethi G., Nishigaki I., The vascular endothelium and human diseases, Int. J. Biol. Sci, 9, pp. 1057-1069, (2013)
[36]
Cahill P.A., Redmond E.M., Vascular endothelium—Gatekeeper of vessel health, Atherosclerosis, 248, pp. 97-109, (2016)
[37]
Ohba K., Sugiyama S., Sumida H., Nozaki T., Matsubara J., Matsuzawa Y., Konishi M., Akiyama E., Kurokawa H., Maeda H., Et al., Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease, J. Am. Heart Assoc, 1, (2012)
[38]
Hong Y.M., Atherosclerotic cardiovascular disease beginning in childhood, Korean Circ. J, 40, pp. 1-9, (2010)
[39]
Rafieian-Kopaei M., Setorki M., Doudi M., Baradaran A., Nasri H., Atherosclerosis: Process, indicators, risk factors and new hopes, Int. J. Prev. Med, 5, pp. 927-946, (2014)
[40]
Beverly J.K., Budoff M.J., Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation, J. Diabetes, 12, pp. 102-104, (2020)